A study to see the efficacy of dextrose prolotherapy in sacroiliac joint pain.
Phase 4
- Conditions
- Health Condition 1: M538- Other specified dorsopathies
- Registration Number
- CTRI/2017/08/009263
- Lead Sponsor
- ESI Institute of Pain Management ESI Hospital Sealdah
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having signs and symptoms of sacro-iliac joint pain.
Patients having pain for more than 6 months.
Patients undergoing conventional therapy but not iterventional therapy.
Exclusion Criteria
Pregnancy
Inflamatory disease
Infection or cellulitis
Peripheral nerve disease
Unhealed fractures or other debilitating diseases.
Cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain in Neumaric Rating Scale (NRS) scoreTimepoint: At day 0, after 2 weeks, 4 weeks and 3 months after last injection
- Secondary Outcome Measures
Name Time Method Roland Moris Disability Questionnaire (RMDQ) scoreTimepoint: At day 0, after 2 weeks, 4 weeks and 3 months after last injection